Numinus Congratulates MAPS on its Phase 3 Study Results Published in...

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing...

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

Clearmind Medicine Closes US$2.25 Million Public Offering

Reunion Neuroscience Inc. Announces FDA Clearance of IND Application to Initiate...

PT442 – Burning Questions About Burning Man: Mud, Ebola, and the...

Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted...

Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering

Second Phase 3 Study of MDMA-assisted Therapy Reports Positive Results, Paving...

BetterLife Pharma to Host Investors Update Call on September 18, 2023

Load more